SYN-004 Safety and Tolerability in Allo-HCT Subjects

Clinical trial NCT04692181 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04692181
Sponsor: Theriva Biologics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics

Start date: 2021-02-15
Primary completion: 2029-09-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.